Your browser doesn't support javascript.
loading
miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC.
Lai, Yi; Kacal, Merve; Kanony, Maraam; Stukan, Iga; Jatta, Kenbugul; Kis, Lorand; Norberg, Erik; Vakifahmetoglu-Norberg, Helin; Lewensohn, Rolf; Hydbring, Per; Ekman, Simon.
Afiliação
  • Lai Y; Department of Oncology-Pathology, Visionsgatan 4, Karolinska Institutet, S-17164, Stockholm, Sweden.
  • Kacal M; Department of Physiology and Pharmacology, Solnavägen 9, Karolinska Institutet, S-17165, Stockholm, Sweden.
  • Kanony M; Department of Oncology-Pathology, Visionsgatan 4, Karolinska Institutet, S-17164, Stockholm, Sweden.
  • Stukan I; Department of Oncology-Pathology, Visionsgatan 4, Karolinska Institutet, S-17164, Stockholm, Sweden.
  • Jatta K; Department of Oncology-Pathology, Visionsgatan 4, Karolinska Institutet, S-17164, Stockholm, Sweden.
  • Kis L; Department of Oncology-Pathology, Visionsgatan 4, Karolinska Institutet, S-17164, Stockholm, Sweden.
  • Norberg E; Department of Physiology and Pharmacology, Solnavägen 9, Karolinska Institutet, S-17165, Stockholm, Sweden.
  • Vakifahmetoglu-Norberg H; Department of Physiology and Pharmacology, Solnavägen 9, Karolinska Institutet, S-17165, Stockholm, Sweden.
  • Lewensohn R; Department of Oncology-Pathology, Visionsgatan 4, Karolinska Institutet, S-17164, Stockholm, Sweden; Theme Cancer, Karolinska University Hospital, S-17176, Stockholm, Sweden.
  • Hydbring P; Department of Oncology-Pathology, Visionsgatan 4, Karolinska Institutet, S-17164, Stockholm, Sweden. Electronic address: Per.Hydbring@ki.se.
  • Ekman S; Department of Oncology-Pathology, Visionsgatan 4, Karolinska Institutet, S-17164, Stockholm, Sweden; Theme Cancer, Karolinska University Hospital, S-17176, Stockholm, Sweden. Electronic address: Simon.Ekman@ki.se.
Biochem Biophys Res Commun ; 511(2): 260-265, 2019 04 02.
Article em En | MEDLINE | ID: mdl-30791979

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serina Endopeptidases / Proteínas de Fusão Oncogênica / Carcinoma Pulmonar de Células não Pequenas / Proteínas de Ciclo Celular / MicroRNAs / Inibidores de Proteínas Quinases / Quinase do Linfoma Anaplásico / Neoplasias Pulmonares / Proteínas Associadas aos Microtúbulos Limite: Humans Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serina Endopeptidases / Proteínas de Fusão Oncogênica / Carcinoma Pulmonar de Células não Pequenas / Proteínas de Ciclo Celular / MicroRNAs / Inibidores de Proteínas Quinases / Quinase do Linfoma Anaplásico / Neoplasias Pulmonares / Proteínas Associadas aos Microtúbulos Limite: Humans Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suécia